In inflamed intestinal tissues and epithelial cells, interleukin 22 signaling increases expression of H19 long noncoding RNA, which promotes mucosal regeneration
Strategies targeting GPx8 may constitute a new therapeutic approach for treating this aggressive form of cancer
Wolverine stack protocol: PDA: 500 mcg to 1 mg subcutaneous, once daily TB-500: 2.0 to 2.5 mg subcutaneous, 2 to 3 times weekly (loading phase), then once weekly (maintenance) Duration: 6 to 8 weeks Timing: PDA and TB-500 can be administered at the same time or at different times during the day
Furthermore, researchers have reported the presence of mitochondrial abnormalities, indicating a causal relationship between mitochondrial dysfunction and PD
Allometric scaling of pharmacodynamic effects (not just pharmacokinetics) from rodents to humans has a poor track record for peptides specifically
Influence of tart cherry juice on indices of recovery following marathon running